Subtype
Inflammatory Myofibroblastic Tumor
CI-CAN-00002917IMTExplore in graph →
Non-malignant2 active trials10 evidence items
Loading cancer entity…
Subtype
CI-CAN-00002917IMTExplore in graph →
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04260009 | Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors | withdrawn | Phase 1 / Phase 2 | 0 | TakedaINDUSTRY | 0 | Mar 5, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Mar 5, 2020source: clinicaltrials